* Elanco Animal Health Inc ELAN.N reported quarterly
adjusted
earnings of 13 cents per share for the quarter ended September
30, lower than the same quarter last year, when the company
reported EPS of 18 cents. The mean expectation of ten analysts
for the quarter was for earnings of 12 cents per share. Wall
Street expected results to range from 10 cents to 13 cents per
share.
* Revenue fell 3.6% to $1.03 billion from a year ago;
analysts
expected $1.03 billion.
* Elanco Animal Health Inc's reported EPS for the quarter
was 73
cents.
* The company reported quarterly net income of $364 million.
* Elanco Animal Health Inc shares had fallen by 12.5% this
quarter and lost 13.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 16.5%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Elanco Animal
Health Inc is $19.50
This summary was machine generated from LSEG data November 7 at
02:43 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.12 0.13 Beat
Jun. 30 2024 0.24 0.30 Beat
Mar. 31 2024 0.26 0.34 Beat
Dec. 31 2023 0.08